PSMA Theranostics: Current Landscape and Future Outlook

SIMPLE SUMMARY: The prognosis for metastatic prostate cancer patients remains poor. Prostate-specific membrane antigen (PSMA) is overexpressed in prostate cancer and is a promising target for both imaging and therapy. In this review paper, we provide an overview of the evidence for PSMA-targeted ima...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hanbo, Koumna, Stella, Pouliot, Frédéric, Beauregard, Jean-Mathieu, Kolinsky, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391520/
https://www.ncbi.nlm.nih.gov/pubmed/34439177
http://dx.doi.org/10.3390/cancers13164023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391520/
https://www.ncbi.nlm.nih.gov/pubmed/34439177
http://dx.doi.org/10.3390/cancers13164023

Ejemplares similares